Black Rock Inc. Soligenix, Inc. Transaction History

Black Rock Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 13, 2023	SELL	$0.4 - $168.0 $148 - $62,160	-370 Reduced 1.88%	19,260 $8,000
Q3 2022 Nov 14, 2022	SELL	$0.51 - $117.79 $292 - $67,611	-574 Reduced 2.84%	19,630 $9,000
Q2 2022 Aug 12, 2022	SELL	$0.4 - $0.75 $38,546 - $72,274	-96,366 Reduced 82.67%	20,204 $12,000
Q1 2022 May 12, 2022	SELL	$0.61 - $0.75 $2,728 - $3,354	-4,473 Reduced 3.7%	116,570 $85,000
Q4 2021 Feb 10, 2022	BUY	$0.66 - $1.1 $3,530 - $5,883	5,349 Added 4.62%	121,043 $80,000
Q3 2021 Nov 09, 2021	SELL	$0.9 - $1.31 $13,413 - $19,524	-14,904 Reduced 11.41%	115,694 $123,000
Q2 2021 Aug 11, 2021	BUY	$0.87 - $1.58 $113,620 - $206,344	130,598 New	130,598 $145,000

Ticker SNGX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,105,200
Market Cap $162M
Description
Soligenix, Inc., a late-stage biopharmaceutical company, focuses on developing and commercializing products to treat rare diseases in the United States. It operates in two segments, Specialized BioTherapeutics and Public Health Solutions. The Specialized BioTherapeutics segment develops SGX301 (HyBryte), a novel photodynamic therapy, which has c...

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

Stay updated on Black Rock Inc. with notifications on news.